Prelude Capital Management, LLC Sea Spine Holdings Corp Transaction History

Prelude Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$6.01 - $8.35 $278,196 - $386,513	46,289 New	46,289 $386,000
Q4 2020 Feb 16, 2021	SELL	$12.76 - $18.33 $2,552 - $3,665	-200 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.07 - $14.82 $1,814 - $2,964	200 New	200 $3,000
Q1 2020 May 15, 2020	SELL	$6.08 - $16.42 $17,887 - $48,307	-2,942 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$10.57 - $13.84 $31,223 - $40,883	-2,954 Reduced 50.1%	2,942 $35,000
Q3 2019 Nov 14, 2019	BUY	$10.51 - $13.32 $9,070 - $11,495	863 Added 17.15%	5,896 $72,000
Q2 2019 Aug 14, 2019	SELL	$12.7 - $15.49 $5,080 - $6,196	-400 Reduced 7.36%	5,033 $67,000
Q1 2019 May 15, 2019	BUY	$13.93 - $17.91 $65,972 - $84,821	4,736 Added 679.48%	5,433 $82,000
Q4 2018 Feb 14, 2019	BUY	$14.25 - $19.66 $4,588 - $6,330	322 Added 85.87%	697 $13,000
Q3 2018 Nov 14, 2018	SELL	$12.25 - $16.29 $22,050 - $29,322	-1,800 Reduced 82.76%	375 $6,000
Q2 2018 Aug 14, 2018	SELL	$9.99 - $14.05 $4,365 - $6,139	-437 Reduced 16.73%	2,175 $27,000
Q1 2018 May 15, 2018	BUY	$9.7 - $11.5 $25,336 - $30,038	2,612 New	2,612 $26,000

767K

Ticker SPNE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,202,800
Description
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion pr...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.